Tenon Medical Closes $4.2M Offering with 11M Shares, 13.3M Warrants
TNON•Tenon Medical closed a $4.2 million public offering issuing 11,052,631 common shares with accompanying warrants for 13,263,159 shares at $0.38 per unit. Proceeds will repay convertible notes, expand commercial footprint via training and hiring, fund clinical research and R&D, and boost inventory, instrumentation and marketing.
1. Offering Details
Tenon Medical issued 11,052,631 shares of common stock and pre-funded warrants together with Common Warrants exercisable for 13,263,159 shares at a combined price of $0.38 per unit, generating $4.2 million in gross proceeds before fees and expenses.
2. Use of Proceeds
Net proceeds are earmarked for partial repayment of outstanding convertible notes, expansion of the commercial footprint through clinician training and hiring additional sales representatives, and growth of the external distribution network.
3. Research, Development and Inventory
Funds will also support ongoing clinical research studies for reimbursement and coverage, future product launches in R&D, and increases to inventory and instrumentation capacities.
4. Warrant and Capital Structure Impact
Common Warrants are immediately exercisable at $0.38 per share with an increase to 16,578,949 warrants if a reverse stock split occurs, creating potential future capital injection and dilution.
